Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
Clinical trial NCT00323063 · TERMINATED
Trial details
- NCT number
- NCT00323063
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2011-04-15
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.